FUKOKU MUTUAL LIFE INSURANCE Co Trims Position in Intuitive Surgical, Inc. $ISRG

FUKOKU MUTUAL LIFE INSURANCE Co lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 48.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,494 shares of the medical equipment provider’s stock after selling 1,400 shares during the quarter. FUKOKU MUTUAL LIFE INSURANCE Co’s holdings in Intuitive Surgical were worth $689,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Riversedge Advisors LLC grew its position in shares of Intuitive Surgical by 1.9% in the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after purchasing an additional 17 shares during the period. Fiduciary Financial Group LLC lifted its position in Intuitive Surgical by 2.1% during the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after buying an additional 19 shares during the period. Prosperity Consulting Group LLC boosted its stake in Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after buying an additional 19 shares during the last quarter. Sunburst Financial Group LLC boosted its stake in Intuitive Surgical by 4.3% in the 4th quarter. Sunburst Financial Group LLC now owns 485 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 20 shares during the last quarter. Finally, WoodTrust Financial Corp grew its holdings in Intuitive Surgical by 0.5% in the 4th quarter. WoodTrust Financial Corp now owns 4,180 shares of the medical equipment provider’s stock valued at $2,367,000 after buying an additional 20 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $426.01 on Friday. Intuitive Surgical, Inc. has a 1-year low of $396.68 and a 1-year high of $603.88. The firm has a market capitalization of $150.88 billion, a P/E ratio of 51.64, a P/E/G ratio of 3.47 and a beta of 1.46. The business’s 50-day simple moving average is $427.27 and its 200-day simple moving average is $479.63.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the prior year, the company earned $1.81 EPS. The company’s revenue was up 23.0% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total value of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This trade represents a 6.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction on Wednesday, April 29th. The shares were sold at an average price of $463.50, for a total transaction of $55,156.50. Following the transaction, the director owned 120 shares in the company, valued at $55,620. The trade was a 49.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock valued at $3,059,135 over the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ISRG. The Goldman Sachs Group set a $558.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, May 27th. Robert W. Baird boosted their target price on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. Truist Financial lowered their target price on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a report on Wednesday, April 15th. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, June 13th. Finally, Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a report on Wednesday, March 11th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $573.42.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts and market commentators say Intuitive Surgical has a strong track record of beating expectations and could do so again in the upcoming quarter, helped by continued procedure growth and healthy demand for its robotic surgery systems. Why Intuitive Surgical (ISRG) Could Beat Earnings Estimates Again
• Positive Sentiment: Recent earnings-review coverage ranked Intuitive Surgical as one of the top performers in its surgical equipment and consumables peer group, reinforcing the company’s leadership position. Q1 Surgical Equipment & Consumables – Specialty Earnings Review: First Prize Goes to Intuitive Surgical (NASDAQ:ISRG)
• Positive Sentiment: Some investors appear to be buying ahead of the mid-July earnings call, citing first-quarter momentum, da Vinci 5 placements, and product-cycle improvements that could support another strong update. Intuitive Surgical Gains as Investors Appear to Position for Mid-July Earnings
• Neutral Sentiment: Wall Street remains divided, with preview pieces highlighting that strong forecasts are being offset by concerns about the stock’s recent weakness and valuation reset. Intuitive Surgical’s Quarterly Earnings Preview: What You Need to Know
• Neutral Sentiment: Broader investor flow data and insider selling activity show mixed signals, with some institutions adding shares while others reduced exposure, and executives continuing to sell stock. This is not a direct business catalyst, but it may contribute to cautious sentiment. Intuitive Surgical Gains as Investors Appear to Position for Mid-July Earnings
• Negative Sentiment: Recent coverage says Intuitive Surgical has fallen sharply from earlier levels and that some investors are concerned about margin pressure and a below-consensus outlook, which has helped keep the stock under pressure. Intuitive Surgical Is Down 28%, and Wall Street Is Piling On. Goldman Sachs Just Said Everyone Is Wrong — and History Is on Its Side.
• Negative Sentiment: Some recent commentary specifically notes the stock fell on a below-consensus forecast, suggesting expectations may have become harder to clear in the near term. Intuitive Surgical (ISRG) Fell on Below-Consensus Forecast

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.